Want to join the conversation?
The medical device manufacturer $BDX reported a 40% dip in its 4Q15 profit, but its revenue grew 38.9% YoverY. Net income for the quarter was $181MM or $0.84 per share, down from $301MM or $1.53 per share in 4Q14. As reported, fourth quarter revenue was $3.06Bil.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.